Since immune cells express DAT and TH, and that CNS dopamine neurons expressing the same markers are decreased in PD patients, we next asked whether or not DAT+ and TH+ PBMCs were altered in PD patients compared to healthy controls, and whether disease duration, sex, age, treatments, and comorbid conditions affect these measures. This evidence concerns the gene TH and Parkinson disease.